$Rocket One(RKTO.US) 🚀

RKTO was already in my portfolio before the latest news cycle, so this trade became a good example of how an existing position can suddenly re-rate when a fresh catalyst appears.

After Hoth Therapeutics rebranded into Rocket One, the market started paying more attention to its new focus on AI chip technology for space, defense, satellites, and low-power radiation-tolerant computing. I also noted that the company’s legacy biotechnology programs are expected to continue under a separate wholly owned subsidiary, which means the pivot is not necessarily a complete abandonment of its previous biotech assets.

The additional AMD AI Developer Program news added momentum and credibility to the story, especially because AI infrastructure and space-related themes are currently getting strong market interest.

That said, I am still treating RKTO as a speculative micro-cap trade rather than a confirmed long-term turnaround. The AMD program is encouraging, but it is not the same as a major commercial contract or guaranteed revenue. Since the stock has already moved sharply higher, my plan is to consider trimming part of the position into strength while keeping some shares for possible further upside.

For me, the key lesson from this trade is that early positioning can pay off when the market finally notices a catalyst, but risk management becomes even more important after a fast move.